Embecta

embecta is a medical technology company focused on diabetes care, spun off from BD (Becton, Dickinson and Company) in April 2022. It develops, manufactures and sells insulin delivery products, mainly pen needles, syringes and safety injection devices, for people living with diabetes. Its mission is to improve the lives of people with diabetes through better insulin delivery and care solutions.